DOJ: Forest promoted Celexa and Lexapro off-label – Medical Marketing and Media

DOJ: Forest promoted Celexa and Lexapro off-label – Medical Marketing and Media: “The Department of Justice (DOJ) is suing Forest Laboratories over the alleged promotion of Celexa and Lexapro off-label, for pediatric use. Forest also paid kickbacks to physicians in return for prescribing the drugs, the DOJ said in a statement.

The allegations, filed in a Massachusetts federal court yesterday, claim Forest hoodwinked physicians by failing to properly disclose results of a negative study regarding Celexa. That study found the drug to be no more effective than a placebo for pediatric use, and that patients taking Celexa displayed an increased suicidality risk.” [MMM Online]

Join a class action. Call us: 800.965.1461